AISTCM-Outcome Measurement of Acute Ischemic Stroke With Traditional Chinese Medicine
AISTCM-The Pathological Pattern Differentiation and Outcome Measurement of Acute Ischemic Stroke Treated With Traditional Chinese Medicine
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment
Enrollment
Phase
Phase
- Phase 4
Contacts and Locations
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100700
- Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
-
-
Guangdong
-
Foshan, Guangdong, China, 528000
- Foshan Hospital of Traditional Chinese Medicine
-
Guangzhou, Guangdong, China, 510120
- 2nd hospital of Zhongshan University
-
Guangzhou, Guangdong, China, 510120
- Neurology Center, Guangdong Province Hospital of Tradtional Chinese Medicine
-
Zhongshan, Guangdong, China
- Zhongshan Hospital of Traditional Chinese Medicine
-
-
Guangxi
-
Nan Ning, Guangxi, China, 530011
- Ruikang Hospital of Traditional Chinese Medicine
-
Nanning, Guangxi, China, 530023
- 1st Hospital of Guangxi college of Traditional Chinese Medicine
-
-
Henan
-
Zhengzhou, Henan, China, 450006
- The 1st Hospital of He'nan College of Traditional Chinese Medicine
-
-
Hubei
-
Wuhan, Hubei, China, 430006
- The teahing hospital of Hubei College of Traditional Chinese Medicine
-
-
Jiangsu
-
Taizhou, Jiangsu, China
- Taizhou Hospital of Traditional Chinese Medicine
-
-
Shandong
-
Jinan, Shandong, China
- Jinan hospital of traditional Chinese Medicine
-
-
Shanghai
-
Shanghai, Shanghai, China, 200000
- Longhua Hospital of Shanghai University of Traditional Chinese Medicine
-
Shanghai, Shanghai, China, 200000
- Shanghai Hospital of Traditional Chinese Medicine
-
Shanghai, Shanghai, China, 200000
- Shuguang hospital of Shanghai university of traditional Chinese medicine
-
Shanghai, Shanghai, China, 200000
- Yueyang Hospital of Shanghai University of Traditional Chinese Medicine
-
Shanghai, Shanghai, China, 200032
- zhongshan hospital of Fudan Unversity
-
Shanghai, Shanghai, China, 200040
- Huashan Hospital of Fudan Unveristy
-
-
Shanxi
-
Xian yang, Shanxi, China, 712000
- The Hosptial of Shanxi College of Traditional Chinese Medicine
-
-
Sichuan
-
Chengdu, Sichuan, China, 610072
- The People's Hospital of Sichuan Province
-
-
Xinjiang
-
Urumqi, Xinjiang, China, 830001
- Xinjiang Uygur Autonomous Region Hospital of Traditional Chinese Medicine
-
-
Zhejiang
-
Hangzhou, Zhejiang, China
- Zhejiang Province Hospital of Traditional Chinese Medicine
-
Wenzhou, Zhejiang, China
- The 2nd Hospital of Wenzhou Medical College
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Ischemic stroke diagnosis by CT/MRI scan
- Yin pattern of Traditional Chinese Medicine Theory
- 40-85 years old
- Total anterior circulation infarcts (TACI), partial anterior territory cerebral infarction (PACI), lacunar anterior circulation infarcts (LACI) type under Oxfordshire Community Stroke Project (OCSP) standard
- NIHSS >=4;
- Glasgow coma scale (GCS) >=7;
- Modified Rankin Scale less than 2 degrees before onset of this stroke
- Informed consent signed by patient or his/her family
Exclusion Criteria:
- Hemorrhagic stroke;
- Coma, GCS<=7;
- Cerebral hernia;
- Serious heart, liver, lung, kidney functional failure;
- Gastrointestinal (GI) bleeding;
- Thrombolysis drugs or surgery was administrated to the patient;
- Not cooperative with physician;
- Psychological disorder;
- Already taken part in other clinical drug trial within the past 3 months
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: placebo
|
|
|
Experimental: Chinese herbal medicine
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
|---|
|
death rate, Barthel Index
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
|---|
|
Glasgow Outcome Scale (GOS)
|
|
Modified Rankin Scale (mRS)
|
|
National Institute of Health Stroke Scale (NIHSS)
|
|
Stroke Specific Quality of Life (SSQOL)
|
|
Scale of Traditional Chinese Medicine (SSTCM)
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Longhui Yang, Chairmam, Branch of Science and Education
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Study Start
Study Completion
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Estimate)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2004BA721A02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.